Israel’s Tel Aviv University (TAU) has made a breakthrough discovery enabling doctors to treat the aggressive blood cancer Mantle Cell Lymphoma (MCL).
Israel’s Tel Aviv University (TAU) has made a breakthrough discovery enabling doctors to treat the aggressive blood cancer Mantle Cell Lymphoma (MCL).
Tel Aviv University (TAU) researchers have developed an innovative system that may treat mantle cell lymphoma (MCL).
© United with Israel 2024 | Privacy Policy